GlassScriptPhysician profile
Ken W Lee
NPI 1841259348
$27,115.12
in general payments reported to CMS, 2019-2025
17 companies · $1,551 in 2025
The $1,551 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $591 · 2020: $204 · 2021: $349 · 2022: $742 · 2023: $13K · 2024: $11K · 2025: $1,551.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $21K · Travel and Lodging: $2,408 · Food and Beverage: $1,821.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $21,000.00 |
| Travel and Lodging | $2,407.79 |
| Food and Beverage | $1,821.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $24,849.16 | 2019-2025 | Aveir, Tendril, Ensite |
| Biosense Webster, INC. | $534.97 | 2020-2023 | Na, Octaray Mapping Catheter |
| Medtronic Vascular, INC. | $389.38 | 2019 | |
| Abbvie INC. | $342.44 | 2024-2025 | |
| Galvanize Therapeutics, INC | $177.65 | 2024 | Aliya System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $177.15 | 2020-2022 | |
| Biotronik Nro, INC. | $121.04 | 2025 | Prospera |
| Biotronik INC. | $115.28 | 2022 | |
| Medtronic, INC. | $99.65 | 2021-2022 | |
| Cardiva Medical, INC. | $90.18 | 2022-2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Boston Scientific Corporation | $63.51 | 2022-2025 | Lux-Dx Insertable Cardiac Monitor, Farapulse |
| Janssen Pharmaceuticals, INC | $57.07 | 2019-2021 | |
| Amgen INC. | $27.59 | 2019-2020 | |
| Stryker Corporation | $22.04 | 2024 | Na |
| Elutia, INC. | $17.17 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $16.34 | 2020 | |
| Pfizer INC. | $14.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ken Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.